Ingevity (NGVT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.74
- EPS estimate
- $1.33
- EPS surprise
- +31.15%
- Revenue surprise
- +0.61%
- Revenue
- $314.1M
- Revenue estimate
- $312.2M
- Reported
- Jul 29, 2026
Ingevity reported Q2 2026 results on July 29, 2026. Earnings per share were $1.74, ahead of the $1.33 estimate by 31.15%. Revenue was $314.1 million, just above the $312.2 million estimate. Compared with Q2 2025, EPS rose 25.2% from $1.39, while revenue fell 14.0% from $365.1 million.
That mix of rising earnings and lower sales runs through the recent record. Annual revenue fell from $1.67 billion in 2022 to $1.24 billion in 2025, down 25.8%. Annual EPS dropped from $6.01 in 2022 to $3.92 in 2023 and $3.58 in 2024, then recovered to $4.53 in 2025. The first half of 2026 brought $2.89 per share, 21.4% more than a year earlier, on revenue down 11.9%. The table's highs, $2.09 per share and $482.0 million in revenue, both came in Q3 2022. Ingevity topped the EPS estimate in 15 of the 20 quarters shown and in seven of the last eight. The exception in that stretch was Q4 2025, 5.26% below.
Q3 results came out between October 27 and November 5 in each of the past five years. That points to late October or early November 2026 for the next report, which will show whether the year-over-year EPS gains continue.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $1.33 | $1.74 | +31.15% | $314.1M | SEC |
| Q1 2026 | May 6, 2026 | $0.83 | $1.15 | +38.77% | $258.0M | SEC |
| Q4 2025 | Feb 25, 2026 | $0.67 | $0.63 | −5.26% | $255.1M | SEC |
| Q3 2025 | Nov 5, 2025 | $1.37 | $1.52 | +11.15% | $333.1M | SEC |
| Q2 2025 | Aug 4, 2025 | $1.16 | $1.39 | +19.57% | $365.1M | SEC |
| Q1 2025 | May 5, 2025 | $0.74 | $0.99 | +34.20% | $284.0M | SEC |
| Q4 2024 | Feb 18, 2025 | $0.31 | $0.95 | +207.84% | $298.8M | SEC |
| Q3 2024 | Oct 29, 2024 | $0.88 | $1.10 | +24.72% | $376.9M | SEC |
| Q2 2024 | Jul 31, 2024 | $1.05 | $1.01 | −4.17% | $390.6M | SEC |
| Q1 2024 | May 1, 2024 | $0.34 | $0.52 | +53.85% | $340.1M | SEC |
| Q4 2023 | Feb 21, 2024 | −$0.10 | $0.21 | +320.36% | $371.7M | SEC |
| Q3 2023 | Nov 1, 2023 | $1.21 | $1.21 | −0.35% | $446.0M | SEC |
| Q2 2023 | Aug 2, 2023 | $1.37 | $1.41 | +2.70% | $481.8M | SEC |
| Q1 2023 | May 3, 2023 | $1.13 | $1.09 | −3.66% | $392.6M | SEC |
| Q4 2022 | Feb 27, 2023 | $0.87 | $0.57 | −34.16% | $383.6M | SEC |
| Q3 2022 | Nov 2, 2022 | $1.69 | $2.09 | +23.44% | $482.0M | SEC |
| Q2 2022 | Aug 2, 2022 | $1.62 | $1.73 | +6.60% | $419.9M | SEC |
| Q1 2022 | May 4, 2022 | $1.04 | $1.62 | +56.30% | $382.8M | SEC |
| Q4 2021 | Feb 23, 2022 | $0.78 | $0.78 | +0.65% | $336.0M | SEC |
| Q3 2021 | Oct 27, 2021 | $1.54 | $1.62 | +5.19% | $376.8M | SEC |
Quarterly revenue
Frequently asked questions
When did Ingevity (NGVT) last report earnings?
Ingevity last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did NGVT beat earnings estimates?
Yes. Ingevity reported EPS of $1.74 for Q2 2026 against a $1.33 estimate — a 31.15% beat.
How much revenue did NGVT report last quarter?
Ingevity reported $314.1M in revenue for Q2 2026, against a consensus estimate of $312.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.